nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—Abdominal pain—Thiotepa—sarcoma	0.00188	0.00188	CcSEcCtD
Gatifloxacin—Body temperature increased—Thiotepa—sarcoma	0.00188	0.00188	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00187	0.00187	CcSEcCtD
Gatifloxacin—Body temperature increased—Dactinomycin—sarcoma	0.00186	0.00186	CcSEcCtD
Gatifloxacin—Abdominal pain—Dactinomycin—sarcoma	0.00186	0.00186	CcSEcCtD
Gatifloxacin—Hypoglycaemia—Doxorubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Gatifloxacin—Paraesthesia—Mitoxantrone—sarcoma	0.00184	0.00184	CcSEcCtD
Gatifloxacin—Loss of consciousness—Etoposide—sarcoma	0.00184	0.00184	CcSEcCtD
Gatifloxacin—Decreased appetite—Vincristine—sarcoma	0.00183	0.00183	CcSEcCtD
Gatifloxacin—Ataxia—Epirubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Gatifloxacin—Dyspnoea—Mitoxantrone—sarcoma	0.00183	0.00183	CcSEcCtD
Gatifloxacin—Somnolence—Mitoxantrone—sarcoma	0.00182	0.00182	CcSEcCtD
Gatifloxacin—Convulsion—Etoposide—sarcoma	0.00181	0.00181	CcSEcCtD
Gatifloxacin—Dyspepsia—Mitoxantrone—sarcoma	0.0018	0.0018	CcSEcCtD
Gatifloxacin—Hypertension—Etoposide—sarcoma	0.0018	0.0018	CcSEcCtD
Gatifloxacin—Constipation—Vincristine—sarcoma	0.0018	0.0018	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Gatifloxacin—Dry skin—Epirubicin—sarcoma	0.00178	0.00178	CcSEcCtD
Gatifloxacin—Decreased appetite—Mitoxantrone—sarcoma	0.00178	0.00178	CcSEcCtD
Gatifloxacin—Chest pain—Etoposide—sarcoma	0.00178	0.00178	CcSEcCtD
Gatifloxacin—Migraine—Doxorubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Gatifloxacin—Constipation—Mitoxantrone—sarcoma	0.00175	0.00175	CcSEcCtD
Gatifloxacin—Hypersensitivity—Thiotepa—sarcoma	0.00175	0.00175	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Epirubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Gatifloxacin—Face oedema—Doxorubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Gatifloxacin—Hypersensitivity—Dactinomycin—sarcoma	0.00174	0.00174	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Vincristine—sarcoma	0.00172	0.00172	CcSEcCtD
Gatifloxacin—Gastritis—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Gatifloxacin—Confusional state—Etoposide—sarcoma	0.00172	0.00172	CcSEcCtD
Gatifloxacin—Muscular weakness—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Etoposide—sarcoma	0.0017	0.0017	CcSEcCtD
Gatifloxacin—Asthenia—Thiotepa—sarcoma	0.0017	0.0017	CcSEcCtD
Gatifloxacin—Infection—Etoposide—sarcoma	0.00169	0.00169	CcSEcCtD
Gatifloxacin—Ataxia—Doxorubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Gatifloxacin—Asthenia—Dactinomycin—sarcoma	0.00169	0.00169	CcSEcCtD
Gatifloxacin—Feeling abnormal—Mitoxantrone—sarcoma	0.00169	0.00169	CcSEcCtD
Gatifloxacin—Asthma—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Gatifloxacin—Dysphagia—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Gatifloxacin—Pruritus—Thiotepa—sarcoma	0.00168	0.00168	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00168	0.00168	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Etoposide—sarcoma	0.00167	0.00167	CcSEcCtD
Gatifloxacin—Tachycardia—Etoposide—sarcoma	0.00166	0.00166	CcSEcCtD
Gatifloxacin—Body temperature increased—Vincristine—sarcoma	0.00166	0.00166	CcSEcCtD
Gatifloxacin—Abdominal pain—Vincristine—sarcoma	0.00166	0.00166	CcSEcCtD
Gatifloxacin—Dry skin—Doxorubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Etoposide—sarcoma	0.00165	0.00165	CcSEcCtD
Gatifloxacin—Pancreatitis—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Gatifloxacin—Urticaria—Mitoxantrone—sarcoma	0.00163	0.00163	CcSEcCtD
Gatifloxacin—Anorexia—Etoposide—sarcoma	0.00162	0.00162	CcSEcCtD
Gatifloxacin—Diarrhoea—Thiotepa—sarcoma	0.00162	0.00162	CcSEcCtD
Gatifloxacin—Body temperature increased—Mitoxantrone—sarcoma	0.00162	0.00162	CcSEcCtD
Gatifloxacin—Abdominal pain—Mitoxantrone—sarcoma	0.00162	0.00162	CcSEcCtD
Gatifloxacin—Diarrhoea—Dactinomycin—sarcoma	0.00161	0.00161	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Doxorubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Gatifloxacin—Hypotension—Etoposide—sarcoma	0.00159	0.00159	CcSEcCtD
Gatifloxacin—Gastritis—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Gatifloxacin—Muscular weakness—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Gatifloxacin—Dysuria—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Gatifloxacin—Neutropenia—Epirubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Gatifloxacin—Dizziness—Thiotepa—sarcoma	0.00157	0.00157	CcSEcCtD
Gatifloxacin—Asthma—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Gatifloxacin—Dysphagia—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Gatifloxacin—Hypersensitivity—Vincristine—sarcoma	0.00155	0.00155	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Gatifloxacin—Paraesthesia—Etoposide—sarcoma	0.00153	0.00153	CcSEcCtD
Gatifloxacin—Pancreatitis—Doxorubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Gatifloxacin—Dyspnoea—Etoposide—sarcoma	0.00152	0.00152	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Epirubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Gatifloxacin—Somnolence—Etoposide—sarcoma	0.00152	0.00152	CcSEcCtD
Gatifloxacin—Hypersensitivity—Mitoxantrone—sarcoma	0.00151	0.00151	CcSEcCtD
Gatifloxacin—Asthenia—Vincristine—sarcoma	0.00151	0.00151	CcSEcCtD
Gatifloxacin—Vomiting—Thiotepa—sarcoma	0.00151	0.00151	CcSEcCtD
Gatifloxacin—Vomiting—Dactinomycin—sarcoma	0.0015	0.0015	CcSEcCtD
Gatifloxacin—Rash—Thiotepa—sarcoma	0.0015	0.0015	CcSEcCtD
Gatifloxacin—Dermatitis—Thiotepa—sarcoma	0.00149	0.00149	CcSEcCtD
Gatifloxacin—Headache—Thiotepa—sarcoma	0.00149	0.00149	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Gatifloxacin—Rash—Dactinomycin—sarcoma	0.00148	0.00148	CcSEcCtD
Gatifloxacin—Decreased appetite—Etoposide—sarcoma	0.00148	0.00148	CcSEcCtD
Gatifloxacin—Asthenia—Mitoxantrone—sarcoma	0.00147	0.00147	CcSEcCtD
Gatifloxacin—Stomatitis—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Gatifloxacin—Constipation—Etoposide—sarcoma	0.00146	0.00146	CcSEcCtD
Gatifloxacin—Conjunctivitis—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Gatifloxacin—Neutropenia—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Gatifloxacin—Dysuria—Doxorubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Gatifloxacin—Diarrhoea—Vincristine—sarcoma	0.00144	0.00144	CcSEcCtD
Gatifloxacin—Sweating—Epirubicin—sarcoma	0.00144	0.00144	CcSEcCtD
Gatifloxacin—Haematuria—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Doxorubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Gatifloxacin—Epistaxis—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Gatifloxacin—Nausea—Thiotepa—sarcoma	0.00141	0.00141	CcSEcCtD
Gatifloxacin—Feeling abnormal—Etoposide—sarcoma	0.0014	0.0014	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Doxorubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Gatifloxacin—Diarrhoea—Mitoxantrone—sarcoma	0.0014	0.0014	CcSEcCtD
Gatifloxacin—Nausea—Dactinomycin—sarcoma	0.0014	0.0014	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Etoposide—sarcoma	0.00139	0.00139	CcSEcCtD
Gatifloxacin—Dizziness—Vincristine—sarcoma	0.00139	0.00139	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Gatifloxacin—Bradycardia—Epirubicin—sarcoma	0.00137	0.00137	CcSEcCtD
Gatifloxacin—Urticaria—Etoposide—sarcoma	0.00135	0.00135	CcSEcCtD
Gatifloxacin—Stomatitis—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Gatifloxacin—Abdominal pain—Etoposide—sarcoma	0.00135	0.00135	CcSEcCtD
Gatifloxacin—Body temperature increased—Etoposide—sarcoma	0.00135	0.00135	CcSEcCtD
Gatifloxacin—Conjunctivitis—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Gatifloxacin—Hepatitis—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Gatifloxacin—Vomiting—Vincristine—sarcoma	0.00134	0.00134	CcSEcCtD
Gatifloxacin—Pharyngitis—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Gatifloxacin—Sweating—Doxorubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Gatifloxacin—Rash—Vincristine—sarcoma	0.00133	0.00133	CcSEcCtD
Gatifloxacin—Dermatitis—Vincristine—sarcoma	0.00133	0.00133	CcSEcCtD
Gatifloxacin—Oedema peripheral—Epirubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Gatifloxacin—Headache—Vincristine—sarcoma	0.00132	0.00132	CcSEcCtD
Gatifloxacin—Epistaxis—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Gatifloxacin—Vomiting—Mitoxantrone—sarcoma	0.0013	0.0013	CcSEcCtD
Gatifloxacin—Visual impairment—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Gatifloxacin—Rash—Mitoxantrone—sarcoma	0.00129	0.00129	CcSEcCtD
Gatifloxacin—Dermatitis—Mitoxantrone—sarcoma	0.00129	0.00129	CcSEcCtD
Gatifloxacin—Headache—Mitoxantrone—sarcoma	0.00128	0.00128	CcSEcCtD
Gatifloxacin—Erythema multiforme—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gatifloxacin—Bradycardia—Doxorubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gatifloxacin—Eye disorder—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Gatifloxacin—Hypersensitivity—Etoposide—sarcoma	0.00126	0.00126	CcSEcCtD
Gatifloxacin—Tinnitus—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Gatifloxacin—Nausea—Vincristine—sarcoma	0.00125	0.00125	CcSEcCtD
Gatifloxacin—Hepatitis—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Gatifloxacin—Asthenia—Etoposide—sarcoma	0.00122	0.00122	CcSEcCtD
Gatifloxacin—Nausea—Mitoxantrone—sarcoma	0.00122	0.00122	CcSEcCtD
Gatifloxacin—Chills—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Gatifloxacin—Pruritus—Etoposide—sarcoma	0.00121	0.00121	CcSEcCtD
Gatifloxacin—Visual impairment—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Gatifloxacin—Erythema—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Diarrhoea—Etoposide—sarcoma	0.00117	0.00117	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Gatifloxacin—Flatulence—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Gatifloxacin—Tension—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Gatifloxacin—Dysgeusia—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Gatifloxacin—Nervousness—Epirubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Gatifloxacin—Back pain—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Gatifloxacin—Dizziness—Etoposide—sarcoma	0.00113	0.00113	CcSEcCtD
Gatifloxacin—Muscle spasms—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Gatifloxacin—Vision blurred—Epirubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Gatifloxacin—Vomiting—Etoposide—sarcoma	0.00108	0.00108	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Gatifloxacin—Agitation—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Gatifloxacin—Rash—Etoposide—sarcoma	0.00107	0.00107	CcSEcCtD
Gatifloxacin—Dermatitis—Etoposide—sarcoma	0.00107	0.00107	CcSEcCtD
Gatifloxacin—Headache—Etoposide—sarcoma	0.00107	0.00107	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gatifloxacin—Vertigo—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gatifloxacin—Syncope—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Gatifloxacin—Palpitations—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Loss of consciousness—Epirubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Gatifloxacin—Convulsion—Epirubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gatifloxacin—Nausea—Etoposide—sarcoma	0.00101	0.00101	CcSEcCtD
Gatifloxacin—Hypertension—Epirubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gatifloxacin—Chest pain—Epirubicin—sarcoma	0.000997	0.000997	CcSEcCtD
Gatifloxacin—Arthralgia—Epirubicin—sarcoma	0.000997	0.000997	CcSEcCtD
Gatifloxacin—Myalgia—Epirubicin—sarcoma	0.000997	0.000997	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—sarcoma	0.000995	0.000995	CcSEcCtD
Gatifloxacin—Anxiety—Epirubicin—sarcoma	0.000993	0.000993	CcSEcCtD
Gatifloxacin—Vertigo—Doxorubicin—sarcoma	0.000973	0.000973	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—sarcoma	0.000971	0.000971	CcSEcCtD
Gatifloxacin—Confusional state—Epirubicin—sarcoma	0.000963	0.000963	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—sarcoma	0.000957	0.000957	CcSEcCtD
Gatifloxacin—Oedema—Epirubicin—sarcoma	0.000955	0.000955	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Epirubicin—sarcoma	0.000955	0.000955	CcSEcCtD
Gatifloxacin—Loss of consciousness—Doxorubicin—sarcoma	0.000952	0.000952	CcSEcCtD
Gatifloxacin—Infection—Epirubicin—sarcoma	0.000949	0.000949	CcSEcCtD
Gatifloxacin—Shock—Epirubicin—sarcoma	0.00094	0.00094	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—sarcoma	0.000939	0.000939	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Epirubicin—sarcoma	0.000935	0.000935	CcSEcCtD
Gatifloxacin—Hypertension—Doxorubicin—sarcoma	0.000935	0.000935	CcSEcCtD
Gatifloxacin—Tachycardia—Epirubicin—sarcoma	0.000932	0.000932	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Epirubicin—sarcoma	0.000924	0.000924	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—sarcoma	0.000922	0.000922	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—sarcoma	0.000922	0.000922	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—sarcoma	0.000922	0.000922	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—sarcoma	0.000919	0.000919	CcSEcCtD
Gatifloxacin—Anorexia—Epirubicin—sarcoma	0.000911	0.000911	CcSEcCtD
Gatifloxacin—Hypotension—Epirubicin—sarcoma	0.000893	0.000893	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—sarcoma	0.000891	0.000891	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—sarcoma	0.000884	0.000884	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—sarcoma	0.000884	0.000884	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—sarcoma	0.000878	0.000878	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00087	0.00087	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—sarcoma	0.00087	0.00087	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Doxorubicin—sarcoma	0.000866	0.000866	CcSEcCtD
Gatifloxacin—Insomnia—Epirubicin—sarcoma	0.000864	0.000864	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—sarcoma	0.000863	0.000863	CcSEcCtD
Gatifloxacin—Paraesthesia—Epirubicin—sarcoma	0.000858	0.000858	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—sarcoma	0.000855	0.000855	CcSEcCtD
Gatifloxacin—Dyspnoea—Epirubicin—sarcoma	0.000852	0.000852	CcSEcCtD
Gatifloxacin—Somnolence—Epirubicin—sarcoma	0.000849	0.000849	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—sarcoma	0.000843	0.000843	CcSEcCtD
Gatifloxacin—Dyspepsia—Epirubicin—sarcoma	0.000841	0.000841	CcSEcCtD
Gatifloxacin—Decreased appetite—Epirubicin—sarcoma	0.000831	0.000831	CcSEcCtD
Gatifloxacin—Hypotension—Doxorubicin—sarcoma	0.000826	0.000826	CcSEcCtD
Gatifloxacin—Constipation—Epirubicin—sarcoma	0.000817	0.000817	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000805	0.000805	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—sarcoma	0.0008	0.0008	CcSEcCtD
Gatifloxacin—Paraesthesia—Doxorubicin—sarcoma	0.000794	0.000794	CcSEcCtD
Gatifloxacin—Dyspnoea—Doxorubicin—sarcoma	0.000788	0.000788	CcSEcCtD
Gatifloxacin—Feeling abnormal—Epirubicin—sarcoma	0.000787	0.000787	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—sarcoma	0.000786	0.000786	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Epirubicin—sarcoma	0.000781	0.000781	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—sarcoma	0.000778	0.000778	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—sarcoma	0.000768	0.000768	CcSEcCtD
Gatifloxacin—Urticaria—Epirubicin—sarcoma	0.000759	0.000759	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—sarcoma	0.000756	0.000756	CcSEcCtD
Gatifloxacin—Abdominal pain—Epirubicin—sarcoma	0.000755	0.000755	CcSEcCtD
Gatifloxacin—Body temperature increased—Epirubicin—sarcoma	0.000755	0.000755	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—sarcoma	0.000729	0.000729	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000723	0.000723	CcSEcCtD
Gatifloxacin—Hypersensitivity—Epirubicin—sarcoma	0.000704	0.000704	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—sarcoma	0.000702	0.000702	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—sarcoma	0.000699	0.000699	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—sarcoma	0.000699	0.000699	CcSEcCtD
Gatifloxacin—Asthenia—Epirubicin—sarcoma	0.000686	0.000686	CcSEcCtD
Gatifloxacin—Pruritus—Epirubicin—sarcoma	0.000676	0.000676	CcSEcCtD
Gatifloxacin—Diarrhoea—Epirubicin—sarcoma	0.000654	0.000654	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—sarcoma	0.000651	0.000651	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—sarcoma	0.000634	0.000634	CcSEcCtD
Gatifloxacin—Dizziness—Epirubicin—sarcoma	0.000632	0.000632	CcSEcCtD
Gatifloxacin—Pruritus—Doxorubicin—sarcoma	0.000625	0.000625	CcSEcCtD
Gatifloxacin—Vomiting—Epirubicin—sarcoma	0.000607	0.000607	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—sarcoma	0.000605	0.000605	CcSEcCtD
Gatifloxacin—Rash—Epirubicin—sarcoma	0.000602	0.000602	CcSEcCtD
Gatifloxacin—Dermatitis—Epirubicin—sarcoma	0.000602	0.000602	CcSEcCtD
Gatifloxacin—Headache—Epirubicin—sarcoma	0.000599	0.000599	CcSEcCtD
Gatifloxacin—Dizziness—Doxorubicin—sarcoma	0.000585	0.000585	CcSEcCtD
Gatifloxacin—Nausea—Epirubicin—sarcoma	0.000568	0.000568	CcSEcCtD
Gatifloxacin—Vomiting—Doxorubicin—sarcoma	0.000562	0.000562	CcSEcCtD
Gatifloxacin—Rash—Doxorubicin—sarcoma	0.000557	0.000557	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—sarcoma	0.000557	0.000557	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—sarcoma	0.000554	0.000554	CcSEcCtD
Gatifloxacin—Nausea—Doxorubicin—sarcoma	0.000525	0.000525	CcSEcCtD
